SciSparc Ltd. (SPRC) stock
SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.04 (-10.77%)
Close on Nov 12, 2026Market cap $129.84KP/E 0.0Yield –
SciSparc ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
For fiscal 2025 it was -$8.14M. The highest annual figure on record is $2.57M in fiscal 2015.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.14M | – |
| FY2024 | Dec 31, 2024 | -$6.83M | – |
| FY2023 | Dec 31, 2023 | -$6.28M | – |
| FY2022 | Dec 31, 2022 | -$8.10M | – |
| FY2021 | Dec 31, 2021 | -$5.74M | – |
| FY2020 | Dec 31, 2020 | -$3.13M | – |
| FY2019 | Dec 31, 2019 | -$3.93M | – |
| FY2018 | Dec 31, 2018 | -$7.09M | – |
| FY2017 | Dec 31, 2017 | -$5.75M | – |
| FY2016 | Dec 31, 2016 | -$2.00M | -177.8% |
| FY2015 | Dec 31, 2015 | $2.57M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | -$1.65M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.43M | – |
See a number that looks wrong?